Personalized LH addition during IVF to improve egg growth
Part of Women’s health & pregnancy clinical trials.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and follow the IVF visit schedule
- You are between 35 and 40 years old
- Your ovarian reserve tests are not too low: AFC 5+ and/or AMH 1.2+
- In a prior IVF/ICSI cycle, you retrieved under 10 eggs (and your starting hormone dose was 225 IU or less under a GnRH-antagonist plan)
- You’ve had up to 3 prior ovarian stimulation cycles, with starting doses 225 IU or less and dose changes not exceeding 300 IU during stimulation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This trial tests whether adding growth hormone and DHEA to your IVF medications can help women with low ovarian reserve get more eggs and improve pregnancy chances. It may be an option if you are over 40, have had few eggs before, or have low egg count markers.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This study tests a one-time injection medicine (corifollitropin alfa) to help older women produce eggs for IVF. It aims to see if this medicine is safe and works well for women aged 36 to 40 with normal ovarian function.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.